“…This has been demonstrated for endostatin (Rehn et al, 2001), angiostatin (Tarui et al, 2001), thrombospondin-1 (for a review, see Bornstein, 2001) and tumstatin (Maeshima et al, 2000). Indeed, when molecules such as angiostatin Mauceri et al, 1998), endostatin (Hanna et al, 2000) or neutralising anti-human VEGF 165 antibodies (Gorski et al, 1999;Lee et al, 2000) are administered together with ionising radiation, the cytotoxic effects of the latter upon endothelial cells are potentiated in vivo, resulting in an enhanced antitumoral effect.…”